Blog

Nov

Price of UniQure gene therapy tops €1.1M, Fund backs RET inhibitors, Promethera bags €25M

0 No comments

admin

blog

Contact Us

Connect With Us On...

From The Blog...

Title: Celgene shells out $7.2B for Receptos in a big bet on autoimmune disease Title: UPDATED: WuXi Healthcare plots a $250M biotech venture fund for U.S., China

Fast-growing R&D services outfit WuXi PharmaTech is marching ahead with plans to wrap a $250 million venture fund aimed at U.S. and China life sciences companies. WuXi filed documents with the SEC last week outlining the goal for WuXi Healthcare Ventures Fund II, which it’s already made a $50 million anchor investment in. …read more […]

View All >>

default

No more posts to load.

Load More Posts

Loading posts...

A1A8B3

link_magnifier

#5C5C5C

off

fadeInDown

/%postname%/

#5C5C5C

off